Tobacco control-debate on harm reduction enters new phase as India implements public smoking ban

The Lancet Oncology

Volumn 9, Issue 12, 2008, Pages 1122-1123

  Bedi, Raman ^a,b   Scully, Crispian ^b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BENZO[A]PYRENE; NITROSAMINE;

CANCER RISK; CIGARETTE SMOKING; DIGESTIVE SYSTEM CANCER; GOVERNMENT REGULATION; HARM REDUCTION; HEAD AND NECK CANCER; HEALTH HAZARD; HUMAN; INDIA; LETTER; POLICY; PRIORITY JOURNAL; QUALITY CONTROL; RISK REDUCTION; SMOKELESS TOBACCO; SMOKING; SMOKING CESSATION;

HARM REDUCTION; HUMANS; INDIA; PUBLIC HEALTH; SMOKING; SMOKING CESSATION; TOBACCO, SMOKELESS;

EID: 56449118063     PISSN: 14702045     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1470-2045(08)70294-8     Document Type: Letter

References (6)

1. Sharma D.C. India pushes ban on smoking in public places. Lancet Oncol 9 (2008) 922
2. Chapman S. Public health advocacy and tobacco control: making smoking history (2007), Blackwell, Oxford
3. Broadstock M. Systemic review of the health effects of modified smokeless tobacco products. NZHTA Report 10 (2007) 129
4. McNeill A., Bedi R., Islam S., Alkhatib M.N., and West R. Levels of toxins in oral tobacco products in the UK. Tob Control 15 (2006) 64-67
5. Stepanov I., Hecht S.S., Ramakrishnan S., and Gupta P.C. Tobacco-specific nitrosamines in smokeless tobacco products marketed in India. Int J Cancer 116 (2005) 16-19
6. Stepanov I., Jensen J., Hatsukami D., and Hecht S.S. Tobacco-specific nitrosamines in new tobacco products. Nicotine Tob Res 8 (2006) 309-313